SCHEMBL5698787

SCHEMBL5698787

CCCCCCCCC(CCCCCC)C(=O)S

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.57
GPR84 Q9NQS5 7/20 0.50
GRIK1 P39086 2/20 0.50
GRIK2 Q13002 2/20 0.50
FFAR1 O14842 2/20 0.50
MAPT P10636 1/20 0.48
LCK P06239 1/20 0.48
PPARD Q03181 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
MAPK1 P28482 1/20 0.46
FFAR4 Q5NUL3 1/20 0.45
ACE2 Q9BYF1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9397701 1.00 CA2 (0.57) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL13539144 1.00 CA2 (0.57) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL8324700 1.00 CA2 (0.57) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL10964151 1.00 CA2 (0.57) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL22612259 1.00 CA2 (0.57) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL8319690 1.00 CA2 (0.57) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL7515977 0.98 CA2 (0.61) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL1649191 0.98 CA2 (0.61) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL22612320 0.98 CA2 (0.61) CA2GPR84GRIK1GRIK2FFAR1
SCHEMBL9092793 0.98 CA2 (0.54) CA2GPR84GRIK1GRIK2FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569482-B1 SYNTHESIS OF INTERMEDIATES IN THE PREPARATION OF ACAT INHIBITORS PFIZER (US) 1995-08-02 EP claimed
EP-1285652-B1 Novel fatty acid analogues for the treatment of hypertension THIA MEDICA AS (NO) 2006-08-16 EP disclosed
EP-1284139-B1 Novel fatty acid analogues for the treatment of fatty liver THIA MEDICA AS (NO) 2006-08-02 EP disclosed
EP-1075260-B1 NOVEL FATTY ACID ANALOGUES FOR THE TREATMENT OF SECONDARY RESTENOSIS THIA MEDICA AS (NO) 2005-10-19 EP disclosed
EP-1075258-B1 NOVEL FATTY ANALOGUES FOR THE TREATMENT OF OBESITY THIA MEDICA AS (NO) 2003-08-20 EP disclosed
EP-1075259-B1 NOVEL FATTY ANALOGUES FOR THE TREATMENT OF DIABETES THIA MEDICA AS (NO) 2003-07-23 EP disclosed
EP-0609960-B1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase PFIZER (US) 1999-03-03 EP disclosed
US-5656634-A N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) PFIZER INC. (US) 1997-08-12 US disclosed
EP-0418071-B1 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase PFIZER (US) 1995-04-26 EP disclosed
US-5362878-A Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) PFIZER INC. (US) 1994-11-08 US disclosed
EP-0609960-A1 New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase PFIZER INC. (US) 1994-08-10 EP disclosed
WO-1992013843-A1 SYNTHESIS OF INTERMEDIATES IN THE PREPARATION OF ACAT INHIBITORS PFIZER INC. (US) 1992-08-20 WO disclosed
WO-1991004027-A1 NEW N-ARYL AND N-HETEROARYLAMIDE AND UREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A: CHOLESTEROL ACYL TRANSFERASE (ACAT) PFIZER INC. (US) 1991-04-04 WO disclosed
EP-0418071-A2 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase PFIZER INC. (US) 1991-03-20 EP disclosed
US-4459158-A THIOALKANOIC ACID DERIVATIVES PHILLIPS PETROLEUM COMPANY (US) 1984-07-10 US disclosed